Chronic occupational exposure to organic solvents. XV. Glycol ether exposure during the manufacture of brakehoses.
Twenty-two persons (20 men and 2 women) were examined for their external and internal exposure to the glycol ether 1-methoxypropan-2-ol (PGME) during the production, leak testing and mounting of brakehoses. For the measurement of external exposure, personal air monitoring was the method of choice. Average concentrations of PGME of 82.2 mg/m3 (22.3 ppm), 68.6 mg/m3 (18.6 ppm) and 11.3 mg/m3 (3.1 ppm) were found in the air of the brakehose production, leak test and mounting areas, respectively. For the estimation of internal exposure to PGME, this glycol ether was measured in both urine and blood. The biological samples were taken post-shift. The highest internal exposure levels were found in the brakehose production section and in the leak test area. The average post-shift concentrations for PGME in workers in the brakehose production section were 4.6 mg/l in urine and 13.5 mg/l in blood; the corresponding figures for workers in the leak test area were 4.2 mg/l in urine and 11.0 mg/l in blood. In blood and urine samples of workers engaged in the mounting area, PGME levels were below the detection limits. The elimination kinetics of PGME were also studied in three highly exposed persons, and mean excretion half-lives of PGME of approximately 4.4 h were found. On the basis of our results we made a rough calculation of a future biological tolerance value: we would except that concentrations of 38-109 mg per litre of blood and 10-31 mg per litre of urine would correspond to the German MAK value for PGME (375 mg/m3).
Hubner
B
B
Institut für Arbeits- und Sozialmedizin, Universität Erlangen-Nürnberg, Federal Republic of Germany.
Lehnert
G
G
Schaller
K H
KH
Welte
D
D
Angerer
J
J
D000328:Adult; D000395:Air Pollutants, Occupational / Q000009:adverse effects*; D004784:Environmental Monitoring; D005260:Female; D006801:Humans; D008297:Male; D008452:Maximum Allowable Concentration; D008657:Metabolic Clearance Rate / Q000502:physiology; D009784:Occupational Diseases / Q000097:blood / Q000139:chemically induced*; D016273:Occupational Exposure / Q000009:adverse effects*; D011409:Propylene Glycols / Q000009:adverse effects* / Q000493:pharmacokinetics; D012307:Risk Factors; D012997:Solvents / Q000009:adverse effects* / Q000493:pharmacokinetics
D000395:Air Pollutants, Occupational; D011409:Propylene Glycols; D012997:Solvents; C005216:propylene glycol methyl ether